Regencell Bioscience Holdings Ltd
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -16,543,260.0% | – | -230.0% | – | – | – | – | – | – | |
| – | -99.9% | – | – | +100.0% | -51.6% | – | – | – | – | – | – | |
| – | -100.0% | -100.0% | +3,099,900.0% | -100.0% | +224,556.0% | -99.9% | +166,311.9% | -99.9% | +100.0% | -112.6% | – | |
| – | -100.2% | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | -100.0% | – | -100.0% | – | -100.0% | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -100.1% | – | -32,348,120.0% | – | -9.3% | – | – | – | – | – | -102.6% | |
| – | – | – | -16,634,566.7% | – | -230.2% | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.